京都大学医学部附属病院 放射線治療科

menu

業績集 2004

2011 | 2010 |
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993

1 Aoki T.,Nagata Y., Negoro Y., Takayama K., Mizowaki T., Kokubo M., Oya N., Mitsumori M., Hiraoka M.:
Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors.,
CT appearance. Radiology, 230(1):101-8, 2004
2 Hiraoka M.:
Current status of and perspectives on chemoradiotherapy: an introduction.,
Int J Clin Oncol., 9(6):413, 2004
3 Hiraoka M., Y. Nagata:
Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience.,
Int J Clin Oncol, 9(5): 352-5, 2004
4 Inoue M., Mukai M., Hamanaka Y., Tatsuta M., Hiraoka M., Kizaka-Kondoh S.:
Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites.,
Int J Oncol, 25(3):713-20,2004
5 Ishimori T., Saga T., Nagata Y., Nakamoto Y., Higashi T., Mamede M., Mukai T., Negoro Y., Aoki T., Hiraoka M., Konishi J.:
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.,
Ann Nucl Med., 18(8): 669-74, 2004
6 Li G., Mitsumori M., Ogura M., Horii N., Kawamura S., Masunaga S., Nagata Y., Hiraoka M.:
Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma.,
Int J Clin Oncol., 9(3): 179-83, 2004
7 Liu J., Shibata T., Qu R., Ogura M., Hiraoka M.:
Influences of the p53 status on hypoxia-induced gene expression.,
J Radiat Res (Tokyo), 45(2): 333-9, 2004
8 Masunaga S., Nagasawa H., Hiraoka M., Sakurai Y., Uto Y., Hori H., Nagata K., Suzuki M., Maruhashi A., Kinashi Y., Ono K.:
Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate TX-2060 as a 10B-carrier in boron neutron capture therapy.,
Anticancer Res., 24(5A): 2975-83, 2004
9 Okumura S., Mitsumori M., Yamauchi C., Kawamura S., Oya N., Nagata Y., Hiraoka M., Kokubo M., Mise K., Kodama H.:
Feasibility of breast-conserving therapy for macroscopically multiple ipsilateral breast cancer.,
Int J Radiat Oncol Biol Phys., 59(1): 146-51, 2004
10 Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., Yamashita T., Niibe Y., Karasawa K., Hayakawa K., Takai Y., Kimura T., Hirokawa Y., Takeda A., Ouchi A., Hareyama M., Kokubo M., Hara R., Itami J., Yamada K.:
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.,
Cancer, 101(7):1623-31, 2004
11 Sai H., Mitsumori M., Yamauchi C., Araki N., Okumura S., Nagata Y., Nishimura Y., Hiraoka M.:
Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.,
Int J Clin Oncol., 9(3):149-53, 2004
12 Sawada A., Yoda K., Kokubo M., Kunieda T., Nagata Y., Hiraoka M.:
A technique for noninvasive respiratory gated radiation treatment system based on a real time 3D ultrasound image correlation: a phantom study.,
Med Phys., 31(2): 245-50, 2004
13 Shibata T.,Fujimoto Y., Jin M. J.,Hiraoka M.:
Transcatheter arterial embolization for large pancreaticoduodenal artery aneurysm with mechanically detachable coils.,
Cardiovasc Intervent Radiol., 27(2): 169-71, 2004
14 Shibata T.,Shibata T.,Maetani Y.,Kubo T.,Itoh K.,Togashi K.,Hiraoka M.:
Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.,
J Vasc Interv Radiol., 15(11): 1323-7, 2004
15 Masunaga S., Nagasawa H., Hiraoka M., Sakurai Y., Uto Y., Hori H., Nagata K., Suzuki M., Maruhashi A., Kinashi Y., Ono K.
The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.,
Appl Radiat Isot., 61(5): 953-8,2004
16 Tabuena R. P., Matsumoto H., Mio T., Nagata Y., Mishima M.:
Metastatic tumor in the right atrium.,
Intern Med., 43(5): 445-6, 2004